These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 30908301)

  • 1. Prasugrel-Induced Thrombocytopenia After Percutaneous Coronary Intervention.
    Hashmi AT; Sabharwal N; Saxena A; Saradna A; Kamholz SL; Hollander G; Shani J
    Am J Ther; 2019; 26(3):e425-e426. PubMed ID: 30908301
    [No Abstract]   [Full Text] [Related]  

  • 2. Prasugrel in Clopidogrel Nonresponders Undergoing Percutaneous Coronary Intervention: The RECLOSE-3 Study (REsponsiveness to CLOpidogrel and StEnt Thrombosis).
    Valenti R; Marcucci R; Comito V; Marrani M; Cantini G; Migliorini A; Parodi G; Gensini GF; Abbate R; Antoniucci D
    JACC Cardiovasc Interv; 2015 Oct; 8(12):1563-70. PubMed ID: 26386764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial Infarction Risk After Discontinuation of Thienopyridine Therapy in the Randomized DAPT Study (Dual Antiplatelet Therapy).
    Stefanescu Schmidt AC; Kereiakes DJ; Cutlip DE; Yeh RW; D'Agostino RB; Massaro JM; Hsieh WH; Mauri L;
    Circulation; 2017 May; 135(18):1720-1732. PubMed ID: 28228427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful Prasugrel Therapy for Recurrent Left Main Stent Thrombosis in a Clopidogrel Hyporesponder.
    Kim YS; Lee SR
    Tex Heart Inst J; 2015 Oct; 42(5):483-6. PubMed ID: 26504448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The saga of the duration of dual antiplatelet therapy after drug-eluting stent placement.
    Helft G
    Arch Cardiovasc Dis; 2015 Oct; 108(10):469-71. PubMed ID: 26432274
    [No Abstract]   [Full Text] [Related]  

  • 6. ISAR-REACT 5 - What have we learned?
    Kubica J; Jaguszewski M
    Cardiol J; 2019; 26(5):427-428. PubMed ID: 31536136
    [No Abstract]   [Full Text] [Related]  

  • 7. Optimal P2Y12 Inhibitor in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Network Meta-Analysis.
    Rafique AM; Nayyar P; Wang TY; Mehran R; Baber U; Berger PB; Tobis J; Currier J; Dave RH; Henry TD
    JACC Cardiovasc Interv; 2016 May; 9(10):1036-46. PubMed ID: 27198684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Unusual Case of Stent-in-Stent Thrombosis.
    Fam JM; den Dekker W; de Graaf P; Regar E
    JACC Cardiovasc Interv; 2015 Dec; 8(15):e261-e262. PubMed ID: 26738681
    [No Abstract]   [Full Text] [Related]  

  • 9. Prasugrel in Clopidogrel Nonresponders: A Way to Improve Secondary Prevention in Patients After Percutaneous Coronary Intervention?
    Huber K
    JACC Cardiovasc Interv; 2015 Oct; 8(12):1571-3. PubMed ID: 26493249
    [No Abstract]   [Full Text] [Related]  

  • 10. Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome Undergoing Complex Percutaneous Coronary Intervention.
    Coughlan JJ; Aytekin A; Ndrepepa G; Schüpke S; Bernlochner I; Mayer K; Neumann FJ; Menichelli M; Richardt G; Wöhrle J; Witzenbichler B; Gewalt S; Xhepa E; Kufner S; Sager HB; Joner M; Ibrahim T; Fusaro M; Laugwitz KL; Schunkert H; Kastrati A; Cassese S
    Circ Cardiovasc Interv; 2021 Jul; 14(7):e010565. PubMed ID: 34130477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prasugrel vs. ticagrelor after acute coronary syndrome: a critical appraisal of the ISAR-REACT 5 trial.
    Sulzgruber P; Niessner A
    Eur Heart J Cardiovasc Pharmacother; 2020 Sep; 6(5):273-274. PubMed ID: 31865384
    [No Abstract]   [Full Text] [Related]  

  • 12. Post percutaneous coronary interventional adverse cardiovascular outcomes and bleeding events observed with prasugrel versus clopidogrel: direct comparison through a meta-analysis.
    Bundhun PK; Huang F
    BMC Cardiovasc Disord; 2018 May; 18(1):78. PubMed ID: 29720092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prasugrel versus clopidogrel for residual thrombus burden in patients with ST-segment elevation myocardial infarction: an optical coherence tomography study.
    Yokota T; Higuma T; Endo T; Nishizaki F; Hanada K; Yokoyama H; Yamada M; Okumura K; Tomita H
    Coron Artery Dis; 2018 Dec; 29(8):663-669. PubMed ID: 30308586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations Between Chronic Kidney Disease and Outcomes With Use of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Report From the PROMETHEUS Study.
    Baber U; Chandrasekhar J; Sartori S; Aquino M; Kini AS; Kapadia S; Weintraub W; Muhlestein JB; Vogel B; Faggioni M; Farhan S; Weiss S; Strauss C; Toma C; DeFranco A; Baker BA; Keller S; Effron MB; Henry TD; Rao S; Pocock S; Dangas G; Mehran R
    JACC Cardiovasc Interv; 2017 Oct; 10(20):2017-2025. PubMed ID: 28780028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of duration of dual antiplatelet therapy in patients with acute coronary syndrome after percutaneous coronary intervention.
    Khan SU; Riaz IB; Rahman H; Lone AN; Raza M; Khan MS; Riaz A; Kaluski E
    Eur J Prev Cardiol; 2019 Mar; 26(4):429-432. PubMed ID: 30152256
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of clopidogrel and potent P2Y 12 -inhibitors on mortality and stroke in patients with acute coronary syndrome or undergoing percutaneous coronary intervention: a systematic review and meta-analysis.
    Aradi D; Komócsi A; Vorobcsuk A; Serebruany VL
    Thromb Haemost; 2013 Jan; 109(1):93-101. PubMed ID: 23197191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thirty days only double antiplatelet therapy after drug-eluting stenting: could a 'short-term' treatment be advantageous?
    Casella G; Resciniti E; Gallo P
    J Cardiovasc Med (Hagerstown); 2018 Feb; 19 Suppl 1():e21-e25. PubMed ID: 29045308
    [No Abstract]   [Full Text] [Related]  

  • 18. A case of in-stent thrombosis in a patient with drug eluting stents during perioperative management with glycoprotein IIb/IIIa inhibitors.
    Singh M; Bolla VH; Berg R
    Catheter Cardiovasc Interv; 2013 Dec; 82(7):1108-12. PubMed ID: 23378243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Foreword.
    Curr Probl Cardiol; 2017 Dec; 42(12):402. PubMed ID: 29032851
    [No Abstract]   [Full Text] [Related]  

  • 20. Eptifibatide-Induced Profound Thrombocytopenia After Percutaneous Intervention for Acute Coronary Syndrome: A Challenging Clinical Scenario.
    Bhatia N; Sawyer RD; Ikram S
    Methodist Debakey Cardiovasc J; 2017; 13(4):248-252. PubMed ID: 29744018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.